Using wearable data to improve cardiovascular risk predictions in women
Official title: Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data - A Cross-sectional Study in Apparently Healthy Women Aged 40 to 69 Years (Frauenherzen)
Run by Insel Gruppe AG, University Hospital Bern · NCT06831890 · Data updated 2026-11-12
This study is testing if information from wearable devices can help better predict heart disease risk in women aged 40-69 when usual health measurements aren't available.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 69 Years |
| Sex | Women only |
| Enrollment | 250 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | August 24, 2023 |
| Main results expected | March 2025 |
| Study ends | March 2025 |
| Registry record updated | February 18, 2025 |
| Trial ID | NCT06831890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40-69 who are fluent in German and own a compatible smartphone.
✕Probably not a fit
Patients with existing cardiovascular diseases, diabetes, chronic kidney disease, or familial hypercholesterolemia will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate whether data from wearable devices can enhance the accuracy of predicting cardiovascular disease risk in women aged 40-69 when traditional metrics like blood pressure and lipid levels are not available. Participants will undergo a screening process, wear a device for a week, and maintain a work and sleep journal. The study will assess the effectiveness of these auxiliary data inputs in refining risk assessments for cardiovascular diseases and menopause-related health issues.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate cardiovascular risk assessments for women, potentially improving preventive care.
How similar studies have gone: While the use of wearable devices in health monitoring is gaining traction, this specific approach to enhancing cardiovascular risk prediction is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fluency in German (written and oral). * Ownership of a smartphone. * Signing the informed consent form. Exclusion Criteria: * Diagnosis of cardiovascular disease. * Diagnosis of diabetes mellitus. * Diagnosis of chronic kidney disease. * Diagnosis of familial hypercholesterolemia. * Incapable of providing informed consent. * Current employment at the Section Gynecological Endocrinology and Reproductive Medicine of the Department for Obstetrics and Gynecology at the Inselspital Bern or any other professional relation to one of the study project leaders / investigators. * Concurrent participation in a clinical intervention study. * Inability to comply with the study procedures for any reason, including language comprehension, psychiatric illness, general inability to get to the study site. * Participant's smartphone not compatible with Fitrockr. * Technical inability of participant's smartphone to connect to the smartwatch.
Where it's running
-
University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Petra Stute, Prof. — University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
- Study coordinator: Petra Stute, Prof.
- Email: petra.stute@insel.ch
- Phone: +41 31 632 1010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual registry for menopause and perimenopause in Australia
This study is creating an online registry to collect information from Australian women about their experiences with menopause and perimenopause to help improve healthcare and support for them.
-
Understanding how menopause affects heart disease risk
This study is trying to see how menopause affects heart disease risk in women by following them for at least 10 years and looking at changes in their heart and blood vessels.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.